BrainsWay gains as Cigna removes prior authorizations for depression therapy
Source: SeekingAlpha
2026-02-18 08:54:36 ET
More on BrainsWay
- BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript
- BrainsWay Ltd. (BWAY) Analyst/Investor Day - Slideshow
- BrainsWay to change in ADS ratio to 1-for-1, effective March 3
- Seeking Alpha’s Quant Rating on BrainsWay
- Historical earnings data for BrainsWay
Read the full article on Seeking Alpha
For further details see:
BrainsWay gains as Cigna removes prior authorizations for depression therapy
BrainsWay Ltd.
NASDAQ: BWAY
BWAY Trading
0.77% G/L:
$12.40 Last:
94,434 Volume:
$12.16 Open:
BWAY Latest News
March 04, 2026 07:30:00 am
Landmark Data Validate BrainsWay's SWIFT(TM) Deep TMS, Beginning a New Era in Depression Treatment
February 25, 2026 08:00:00 am
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026
February 23, 2026 08:00:00 am
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day
BWAY Stock Data
$449,653,703
18,680,536
N/A
14
N/A
Medical Equipment & Supplies
Healthcare
IL
Jerusalem
